RBC Capital Markets today reaffirms its sector performer investment rating on Imperial Brands Plc (LON:IMB) and raised its price target to 1700p (from 1600p).
Biotherapeutics company Avacta Group said it had entered into an exclusive distribution agreement with Medusa19 for direct-to-consumer sales of a saliva-based test for the Covid-19...